CX3CL1 and neoplasm: The C1 subtype was enriched for a constellation of protective markers for prognosis such as high infiltration of CD8+ T cells, plasma cells, dendritic cells, and activation of CX3CL1. CD8+ T cells are the main force in maintaining anti-tumor immune responses (29).